MedTrace Pharma
Lyngby · Founded 2015
About MedTrace Pharma
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner. By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at the same time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $63.4M
- Funding stage: Late Stage Venture
- Last round: Series F (May 2025)
- Website: https://medtracepharma.com/
- Phone: +45 28 10 41 49
Industries & Categories
Health Care, Health Diagnostics, Life Science, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/medtrace-pharma-99641 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.